Area of interest: Life science
-
Gesynta Pharma raises 26.5 MEUR
(Stockholm, is developing a drug candidate for the treatment of endometriosis): Has raised 26.5 MEUR in a funding round led by Innovestor Life Science, with participation from Hadean Ventures, Linc, Foreground Capital, Catalyze Capital, Stephen Industries, Amboy Street Ventures, and Industrifonden with member Peter Wolpert. The funding will support a Phase II clinical trial in Europe.
-
Vaja raises 4.35 MSEK
(Stockholm, wind-adaptive technology for solar parks): Has raised 4.5 MSEK in a funding round from Node.vc with founding member John Elvesjö and members Daniela Sjunnesson, Rebecca Sjödin, Mårten Skogö, Henrik Tellving, and Andy Johnston. “We have a humble ambition to revolutionize the global solar park market,” comments Henrik Eskilsson.
-
AnaCardio raises 19 MUSD
(Stockholm, develops novel drugs to treat heart failure): Has raised 19 MUSD in a funding round from Novo Holdings, Pureos Bioventures, Sound Bioventures, Flerie, Fredrik andAnn-Helene Ljungström alongside Industrifonden with member Peter Wolpert. “We now have the data and funding to accelerate the further clinical development of our first-in-class inotrope to improve the lives of patients with heart failure,” comments…
-
Cellevate raises 3.2 MEUR
(Lund, develops the next generation of cell culture systems designed to revolutionize biomanufacturing): Has raised 3.2 MEUR in a funding round from the EIC and Industrifonden with member Peter Wolpert. “This renewed investment is dedicated to achieving the most important milestone for Cellevate: the successful global launch, commercialization, and sales of the first nanofiber-based microcarriers in upstream bioprocessing,” comments Laura Chirica.
-
Amferia raises 1.2 MEUR
(Gothenburg, medical devices that kill bacteria, even resistant bacteria, without harming the body): Has raised 1.2 MEUR in a funding round from new and existing investors, including member Björn Engström. “Antibiotics are absolutely essential. Without them, we cannot survive. Our technology is not about replacing antibiotics but helping healthcare professionals use them more effectively,” comments Anand Rajasekharan,…
-
Cetasol raises 2 MEUR
(Gothenburg, AI-powered energy optimization solutions for marine sustainability): Has raised 2 MEUR in a funding round from Sarsia, ShipsFocus and Impact X Capital. Early investors in Cetasol include member Daniel Rundgren. Cetasol’s platform is an AI-driven decision support system to reduce emissions through energy optimization. It’s compatible with any vessel, offering actionable insights and real-time support.
-
Photoncycle raises 5 MEUR
(Oslo, is developing a space-effective and autonomous energy system powered by the sun): Has raised 5 MEUR in a funding round from Lifeline Ventures, Momentum Partners, Eviny Ventures and Luminar Ventures with members Magnus Bergman and Louise Hagen. “The team’s groundbreaking work in energy storage has the potential to revolutionize how we approach renewable energy, making European households energy self-sufficient,” comments Jacob Key, Founding Partner…
-
DREV raises 8 MSEK
(Gothenburg, specializes in manufacturing contamination control solutions for battery factories and its value chains): Has raised 8 MSEK in a funding round from Unconventional Ventures with members Nora Bavey and Thea Messel. “DREV’s innovative approach to battery manufacturing safety and material recovery will not only redefine industry standards but also make a significant impact on environmental sustainability,” comments Nora Bavey.
-
Agteria Biotech raises 16 MSEK
(Stockholm, a novel patent-pending molecule with a 70% efficiency in reducing methane from burping and farting cows): Has raised 16 MSEK in a funding round from Norrsken Launcher with members Erik Engellau-Nilsson, Fredrik Jung Abbou and founding member Ash Pournouri alongside Mudcake with member Anna Nordell Westling and founding member Erik Byrenius. “In my seven years at Norrsken, I have not seen a single case that…
